GgoogleDE first seen 16 h ago, last 13 h ago, peak #2

OpenAI acquires drug development tool to speed research

Original: open ai

OpenAI has acquired a tool designed to accelerate drug development workflows, a field where research and testing are notoriously slow. The move signals OpenAI's push to apply its artificial intelligence beyond chatbots and into pharmaceutical research, where AI could shorten discovery timelines and reduce costs. Industry watchers see it as part of a broader race among AI companies to expand into science and healthcare applications.

Why now: People are discussing OpenAI's expansion into healthcare and drug discovery following the acquisition news.

OpenAI Interesting Engineering

Open on google →

Evidence

OpenAI acquires drug tool to speed slow drug development workflows · Interesting Engineering
OpenAI Buys Drug Development Company Orchestra Bio · The Information
OpenAI Acquisition of Orchestra Bio Shakes Veeva Systems (VEEV) Stock · GuruFocus
Judge Dismisses Sexual Abuse Lawsuit Against Sam Altman Brought By His Sister · Forbes

Elsewhere

API: https://socialmediatrends-api.osmike.com/v1/trends/3037178